Rubix LS

Biotechnology ResearchMassachusetts, United States11-50 Employees

Rubix LS, a pioneering research catalyst (CRO+), offers a unique clinical and drug development approach. Leveraging personalized AI and data from over 12 million patients, we specialize in inclusive, patient-centered research. Our services extend from licensing to guiding therapies through clinical trials (Phase I - Phase IV), ensuring inclusivity at every stage. We form strong alliances to secure FDA approval, fill gaps in rare diseases, and guarantee efficient market navigation. Our culturally competent research and community focus drive healthcare innovation.

For more information, visit Rubix LS's website.

Sign up for free to view info

Email Format Employee directory